NuVasive Reports $132.9M 3Q Revenue, 10.5% Increase

NuVasive, a spine device company, recently announced revenue of $132.9 million during the third quarter of 2011, a 10.5 percent increase over the same period last year, according to a NuVasive news release.

Advertisement

Company chairman and CEO Alex Lukianov attributed the company’s success to transactions that enhanced its penetration into the lateral lumbar interbody fusion market and NeuroVision market. The additional acquisition of Impulse Monitoring increased the company’s platform during the third quarter as well.

Related Articles on Orthopedic Device Companies:

Integra LifeSciences Reports $202M 3Q Revenue, Driven by Orthopedics Products

Overseas Markets Drive Zimmer’s 3Q Net Sales Increase

Orthofix Spine Sales Decrease Offset by Orthopedic Sales Increase

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.